Evidence map›Paper›PMID 36614165›Full record

ArticleInternational journal of molecular sciences2022

Therapeutic Potency of Induced Pluripotent Stem-Cell-Derived Corneal Endothelial-like Cells for Corneal Endothelial Dysfunction.

Seongjun So, Yoonkyung Park, Soon Suk Kang, Jongsuk Han, Jeong Hye Sunwoo, Whanseo Lee, Jin Kim, Eun Ah Ye, Jae Yong Kim, Hungwon Tchah and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
9.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Guidelines for evaluating endothelial function in vascular tissue.American journal of physiology. Heart and circulatory physiology · 2026
    Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Seongjun SoDepartment of Biomedical Science, CHA Advanced Research Institute, College of Life Science and Center for Embryo and Stem Cell Research, CHA University, Seongnam 13488, Republic of Korea.ORCID 0000-0002-0344-2483
Yoonkyung ParkDepartment of Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.
Soon Suk KangDepartment of Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.
Jongsuk HanDepartment of Biomedical Science, CHA Advanced Research Institute, College of Life Science and Center for Embryo and Stem Cell Research, CHA University, Seongnam 13488, Republic of Korea.
Jeong Hye SunwooDepartment of Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.
Whanseo LeeDepartment of Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.ORCID 0000-0003-4785-4372
Jin KimDepartment of Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.
Eun Ah YeDepartment of Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.
Jae Yong KimDepartment of Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.ORCID 0000-0001-8571-8350
Hungwon TchahDepartment of Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.
Eunju KangDepartment of Biomedical Science, CHA Advanced Research Institute, College of Life Science and Center for Embryo and Stem Cell Research, CHA University, Seongnam 13488, Republic of Korea.ORCID 0000-0002-7240-7868
Hun LeeDepartment of Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.
Ulsan College · KRCHA University · KR

Funding

Asan Institute for Life Sciences 2022IP0019-1, 2021IP0061-2Ministry of Health and Welfare 21C0723L1-11Ministry of Health and Welfare 9991006821, KMDF_PR_20200901_0148National Research Foundation of Korea 2020M3A9E4036527NCIRD CDC HHS U01 IP000019
6 · The paper itself

Abstract

Corneal endothelial cells (CECs) do not proliferate or recover after illness or injury, resulting in decreased cell density and loss of pump/barrier function. Considering the shortage of donor cornea, it is vital to establish robust methods to generate CECs from induced pluripotent stem cells (iPSCs). We investigated the efficacy and safety of transplantation of iPSC-derived CECs into a corneal endothelial dysfunction (CED) rabbit model. iPSCs were generated from human fibroblasts. We characterized iPSCs by demonstrating the gene expression of the PSC markers

Indexed as

Induced Pluripotent Stem Cells1-(5-Isoquinolinesulfonyl)-2-MethylpiperazineAnimalsCell DifferentiationCells, CulturedCorneaEndothelial CellsEndothelium, CornealHumansRabbits1-(5-Isoquinolinesulfonyl)-2-Methylpiperazinefasudilcell injectioncell therapycorneal endothelial cellscorneal endothelial dysfunctioninduced pluripotent stem cell

Identifiers

PMID36614165
PMCPMC9821383
OpenAlexW4313391768

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.